Patents by Inventor Nicole Zantek

Nicole Zantek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070161064
    Abstract: Method and kits are provided for the detection and diagnosis of metastatic disease. More particularly, the methods and kits employ compounds that can detect EphA2, a specific epithelial cell tyrosine kinase that is overexpressed in metastatic tumor cells. In one embodiment the compound is an antibody capable of binding to an epitope of EphA2.
    Type: Application
    Filed: March 12, 2007
    Publication date: July 12, 2007
    Applicant: Purdue Research Foundation
    Inventors: Michael Kinch, Nicole Zantek
  • Publication number: 20060088541
    Abstract: The present invention is directed to compounds and methods for the treatment of cancer. The compounds of this invention have specificity for EphA2, an epithelial cell tyrosine kinase that is overexpressed in metastatic tumor cells. The compounds used in accordance with this invention may be provided in a pharmaceutical composition for treatment of metastatic cancer.
    Type: Application
    Filed: December 8, 2005
    Publication date: April 27, 2006
    Applicant: Purdue Research Foundation
    Inventors: Michael Kinch, Nicole Zantek, Patrick Hein
  • Publication number: 20050169931
    Abstract: The present invention is directed to compounds and methods for the treatment of metastatic disease. The compounds of this invention have specificity for EphA2, an epithelial cell tyrosine kinase that is overexpressed in metastatic tumor-cells. The compounds used in accordance with this invention may be provided in a pharmaceutical composition for treatment of metastatic disease.
    Type: Application
    Filed: February 22, 2005
    Publication date: August 4, 2005
    Applicant: Purdue Research Foundation
    Inventors: Michael Kinch, Nicole Zantek, Patrick Hein